Spravato (Esketamine)
Asian Journal of Nursing Education and Research August 15, 2023 V. Nirosha, V. Gayathri
Spravato, containing esketamine, is a treatment for adults with treatment-resistant major depression, used alongside an SSRI or SNRI after at least two other treatments have failed. It is typically combined with psychological or behavioral therapy. The text describes depression as more than temporary sadness and positions Spravato as an option for those who have not responded to prior treatments.